Fig. 2From: Intriguing insight into unanswered questions about Mpox: exploring health policy implications and considerationsSources: Highlights of prescribing information: JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating), ACAM2000 [Smallpox (Vaccinia) Vaccine, Live]Informed consent between healthcare workers and individuals for getting the suitable vaccine, either JYNNEOS or ACAM2000, with the warning that the patient must be a patient in the hospital for a reasonable time for clinical surveillance, as there is a risk of developing severe allergic manifestations such as suffocation, swelling, tachycardia or dizziness, which are life-threatening conditions Back to article page